Reports

14158 Results (Page 556 of 567)

All Market Research Reports

Pharmaceuticals

Vietnam Clinical Nutrition Market Analysis

The Vietnam Clinical Nutrition Market was valued at $153.3 Mn in 2023 and is projected to grow at a CAGR of 5.57% from 2023 to 2023, to $224.1 Mn by 2030. The key drivers of this industry are increasing prevalence of chronic diseases and metabolic disorders, aging population, increasing awareness of the importance of nutrition for health, product innovations and technological advancements, government initiatives and rising healthcare expenditure, rising incidence of malnutrition especially in paediatric patients which has contributed to market growth. The industry is primarily dominated by players such as Danone Nutrition, Abbott Nutrition, Pfizer Inc, Bayer AG, Nestle, Baxter International Inc Ltd, Mead Johnson & Company, LLC among others.

PUBLISHED: Jul, 2024 | FORMAT: PPT | LAST UPDATED: Jul, 2024 | PRICE: $3999

Digital Health

Saudi Arabia Digital Biomarkers Market Analysis

Saudi Arabia Digital Biomarkers Market was valued at $49.30 Mn in 2023 and is predicted to grow at a CAGR of 23.8% from 2023 to 2030, to $219.73 Mn by 2030. The key drivers of this industry include advancements in technology, the growing prevalence of chronic diseases, rising healthcare costs, and government initiatives. The industry is primarily dominated by ActiGraph LLC, AliveCor Inc., Koneksa, and Altoida Inc. among others.

PUBLISHED: Jul, 2024 | FORMAT: PPT | LAST UPDATED: Jul, 2024 | PRICE: $3999

Medical Devices

Vietnam Breast Pump Market Report

The Vietnam Breast Pump Market was valued at $14.7 Mn in 2023 and is predicted to grow at a CAGR of 8.83% from 2023 to 2030, to $26.6 Mn by 2030. The key drivers of the market include the rising female workforce, enhanced features, and consumer awareness. The prominent players in the Vietnam Breast Pump Market are Asia Connection, Pigeon, Playtex, Ameda, Avent, and Evenflo, among others.

PUBLISHED: Sep, 2024 | FORMAT: PPT | LAST UPDATED: Sep, 2024 | PRICE: $3999

Pharmaceuticals

Philippines Cancer Induced Bone Diseases Therapeutics Market

Philippines Cancer Induced Bone Disease Therapeutics Market valued at $3 Mn in 2022, projected to reach $5 Mn by 2030 with a 6.3% CAGR. The key drivers of this industry include increasing cancer incidence, expanding healthcare infrastructure, and government initiatives. The industry is primarily dominated by players such as Pharex Healthcare, Bayer, Merck, UniLab, TGP Group, Pascual Laboratories, Amgen, and Novartis among others.

PUBLISHED: Apr, 2024 | FORMAT: PPT | LAST UPDATED: Apr, 2024 | PRICE: $3999

Pharmaceuticals

Egypt Clinical Nutrition Market Analysis

The Egypt Clinical Nutrition Market was valued at $85.9 Mn in 2023 and is projected to grow at a CAGR of 6.84% from 2023 to 2023, to $136.5 Mn by 2030. The key drivers of this industry are increasing prevalence of chronic diseases and metabolic disorders, aging population, increasing awareness of the importance of nutrition for health, product innovations and technological advancements, government initiatives and rising healthcare expenditure, rising incidence of malnutrition especially in paediatric patients which has contributed to market growth. The industry is primarily dominated by players such as Bio Pharma, Eva Pharma, Bio Pure, SEDICO, Abbott Nutrition, Mead Johnson & Company, LLC among others

PUBLISHED: Jul, 2024 | FORMAT: PPT | LAST UPDATED: Jul, 2024 | PRICE: $3999

Digital Health

UAE Digital Biomarkers Market Analysis

UAE Digital Biomarkers Market was valued at $14.50 Mn in 2023 and is predicted to grow at a CAGR of 23.3% from 2023 to 2030, to $62.82 Mn by 2030. The key drivers of this industry include the rising prevalence of chronic diseases, government initiatives, increased tech adoption, and focus on preventative care. The industry is primarily dominated by ActiGraph LLC, AliveCor Inc., Koneksa, and Altoida Inc. among others.

PUBLISHED: Jul, 2024 | FORMAT: PPT | LAST UPDATED: Jul, 2024 | PRICE: $3999

Medical Devices

Egypt Breast Pump Market Report

The Egypt Breast Pump Market was valued at $8.2 Mn in 2023 and is predicted to grow at a CAGR of 10.1% from 2023 to 2030, to $16.1 Mn by 2030. The key drivers of the market include improving healthcare infrastructure, growing consumer awareness, and rising disposable incomes. The prominent players in the Egypt Breast Pump Market are Bistos, Ameda, Avent, Evenflo, and Pigeon, among others.

PUBLISHED: Sep, 2024 | FORMAT: PPT | LAST UPDATED: Sep, 2024 | PRICE: $3999

Pharmaceuticals

Malaysia Cancer Induced Bone Disease Therapeutics Market

Malaysia Cancer Induced Bone Disease Therapeutics Market valued at $2 Mn in 2022, projected to reach $3 Mn by 2030 with a 6% CAGR. The key drivers of this industry include the increasing cancer incidence, government initiatives, and improved healthcare infrastructure. The industry is primarily dominated by players such as IHH Healthcare, Bayer, Merck, Pharmaniaga, Duopharma, Maypharm, Amgen, and Novartis among others.

PUBLISHED: Apr, 2024 | FORMAT: PPT | LAST UPDATED: Apr, 2024 | PRICE: $3999

Pharmaceuticals

Spain Kidney Cancer Therapeutics Market Analysis

The Spain Kidney Cancer Therapeutics Market was valued at $121.40 Mn in 2023 and is predicted to grow at a CAGR of 3.86% from 2023 to 2030, to $158.25 Mn by 2030. The key drivers of this industry include the increasing prevalence of kidney cancer due to lifestyle and environmental factors, early detection, and advancement in diagnostic tools. The key players in the industry are Pfizer, Novartis, Grupo Ferrer, Laboratorios Farmacéuticos Rovi, Roche, Bristol Myers Squibb, and AstraZeneca among others.

PUBLISHED: Jun, 2024 | FORMAT: PPT | LAST UPDATED: Jun, 2024 | PRICE: $3999

Pharmaceuticals

Kenya Clinical Nutrition Market Analysis

The Kenya Clinical Nutrition Market was valued at $21.5 Mn in 2023 and is projected to grow at a CAGR of 6.44% from 2023 to 2023, to $33.2 Mn by 2030. The key drivers of this industry are increasing prevalence of chronic diseases and metabolic disorders, aging population, increasing awareness of the importance of nutrition for health, product innovations and technological advancements, government initiatives and rising healthcare expenditure, rising incidence of malnutrition especially in paediatric patients which has contributed to market growth. The industry is primarily dominated by players such as Nutrivea, Healthwise Kenya, Haltons Pharmacy, Mead Johnson & Company, GSK, Unilever among others.

PUBLISHED: Jul, 2024 | FORMAT: PPT | LAST UPDATED: Jul, 2024 | PRICE: $3999

Digital Health

Brazil Digital Biomarkers Market Analysis

Brazil Digital Biomarkers Market was valued at $72.50 Mn in 2023 and is predicted to grow at a CAGR of 23.3% from 2023 to 2030, to $314.11 Mn by 2030. The key drivers of this industry include advancements in technology, the growing prevalence of chronic diseases, and rising healthcare costs. The industry is primarily dominated by ActiGraph LLC, AliveCor Inc., Koneksa, and Altoida Inc. among others.

PUBLISHED: Jul, 2024 | FORMAT: PPT | LAST UPDATED: Jul, 2024 | PRICE: $3999

Medical Devices

Kenya Breast Pump Market Report

The Kenya Breast Pump Market was valued at $2.1 Mn in 2023 and is predicted to grow at a CAGR of 9.7% from 2023 to 2030, to $3.9 Mn by 2030. The key drivers of the market include the improving healthcare infrastructure, growing consumer awareness, and rising disposable incomes. The prominent players of the Kenya Breast Pump Market are Amaze Surgicare, Chemco, Medela, Ameda, Avent, Evenflo, Pigeon, Playtex, Perifit, and Philips Avent, among others.

PUBLISHED: Sep, 2024 | FORMAT: PPT | LAST UPDATED: Sep, 2024 | PRICE: $3999

Pharmaceuticals

Mexico Cancer Induced Bone Disease Therapeutics Market

Mexico Cancer Induced Bone Disease Therapeutics Market valued at $20 Mn in 2022, projected to reach $31 Mn by 2030 with a 6.05% CAGR. The key drivers of this industry include the increasing incidence of cancer, improved diagnostics and treatment, and expanding treatment options. The industry is primarily dominated by players such as Amgen, Novartis, Pfizer, Roche, Eli Lilly, Genomma, and Bayer among others.

PUBLISHED: Apr, 2024 | FORMAT: PPT | LAST UPDATED: Apr, 2024 | PRICE: $3999

Pharmaceuticals

South Africa Clinical Nutrition Market Analysis

The South Africa Clinical Nutrition Market was valued at $199.4 Mn in 2023 and is projected to grow at a CAGR of 6.57% from 2023 to 2023, to $311.2 Mn by 2030. The key drivers of this industry are increasing prevalence of chronic diseases and metabolic disorders, aging population, increasing awareness of the importance of nutrition for health, product innovations and technological advancements, government initiatives and rising healthcare expenditure, rising incidence of malnutrition especially in paediatric patients which has contributed to market growth. The industry is primarily dominated by players such as Herbalife Nutrition, Optimum Nutrition, Abbott Nutrition, Pfizer Inc, Nestle, Mead Johnson & Company, LLC among others.

PUBLISHED: Jul, 2024 | FORMAT: PPT | LAST UPDATED: Jul, 2024 | PRICE: $3999

Digital Health

Mexico Digital Biomarkers Market Analysis

Mexico Digital Biomarkers Market was valued at $43.50 Mn in 2023 and is predicted to grow at a CAGR of 22.55% from 2023 to 2030, to $180.59 Mn by 2030. The key drivers of this industry include rising chronic disease burden, increased smartphone penetration, growing focus on preventative care, and government initiatives. The industry is primarily dominated by ActiGraph LLC, AliveCor Inc., Koneksa, and Altoida Inc. among others.

PUBLISHED: Jul, 2024 | FORMAT: PPT | LAST UPDATED: Jul, 2024 | PRICE: $3999

Medical Devices

South Africa Breast Pump Market Report

The South Africa Breast Pump Market was valued at $19.1 Mn in 2023 and is predicted to grow at a CAGR of 9.83% from 2023 to 2030, to $36.8 Mn by 2030. The key drivers of the market include the rising female workforce, technological features, and growing awareness. The prominent players in the South Africa Breast Pump Market are Bistos, Ameda, Avent, Evenflo, and Pigeon, among others.

PUBLISHED: Sep, 2024 | FORMAT: PPT | LAST UPDATED: Sep, 2024 | PRICE: $3999

Pharmaceuticals

Japan Cancer Induced Bone Diseases Therapeutics Market

Japan Cancer Induced Bone Disease Therapeutics Market valued at $81 Mn in 2022, projected to reach $132 Mn by 2030 with a 6.3% CAGR. The key drivers of this industry include the increasing cancer incidence, technological advancements, and unmet medical needs. The industry is primarily dominated by players such as Daiichi Sankyo, Bayer, Merck, Chugai, Takeda, Novartis, Amgen, and Eisai among others.

PUBLISHED: Apr, 2024 | FORMAT: PPT | LAST UPDATED: Apr, 2024 | PRICE: $3999

Pharmaceuticals

Brazil Congestive Heart Failure Therapeutics Market Analysis

The Brazil Congestive Heart Failure Therapeutics Market is anticipated to experience a growth from $258 Mn in 2022 to $436 Mn by 2030, with a CAGR of 6.8% during the forecast period of 2022-2030. An expanding patient base due to rising cardiac disease prevalence, increased healthcare access around the country, and a thriving R&D environment are the key factors driving the market growth in Brazil. The Brazil Congestive Heart Failure Therapeutics Market encompasses various key players across different therapeutic segments, including Johnson & Johnson, Merck, Novartis, Pfizer, Sanofi, Hypera Pharma, Ache Laboratories, EMS Pharma, Neo Quimica, Teuto Brasileiro, etc, among various others.

PUBLISHED: Jun, 2024 | FORMAT: PPT | LAST UPDATED: Jun, 2024 | PRICE: $3999

Pharmaceuticals

India Clinical Nutrition Market Analysis

The India Clinical Nutrition Market was valued at $557.8 Mn in 2023 and is projected to grow at a CAGR of 8.34% from 2023 to 2023, to $977.2 Mn by 2030. The key drivers of this industry are increasing prevalence of chronic diseases and metabolic disorders, aging population, increasing awareness of the importance of nutrition for health, product innovations and technological advancements, government initiatives and rising healthcare expenditure, rising incidence of malnutrition especially in paediatric patients which has contributed to market growth. The industry is primarily dominated by players such as Sun Pharmaceuticals, Zydus Wellness, Glenmark Pharmaceuticals, Zeon Lifesciences, Nestle, Mead Johnson & Company, LLC among others.

PUBLISHED: Jul, 2024 | FORMAT: PPT | LAST UPDATED: Jul, 2024 | PRICE: $3999

Digital Health

Spain Digital Biomarkers Market Analysis

Spain Digital Biomarkers Market was valued at $55.97 Mn in 2023 and is predicted to grow at a CAGR of 21.3% from 2023 to 2030, to $216.26 Mn by 2030. The key drivers of this industry include the high burden of chronic diseases, the advanced healthcare system, and the growing interest in personalized medicine. The industry is primarily dominated by ActiGraph LLC, AliveCor Inc., Koneksa, and Altoida Inc. among others.

PUBLISHED: Jul, 2024 | FORMAT: PPT | LAST UPDATED: Jul, 2024 | PRICE: $3999

Medical Devices

India Breast Pump Market Report

The India Breast Pump Market was valued at $53.5 Mn in 2023 and is predicted to grow at a CAGR of 11.6% from 2023 to 2030, to $115.3 Mn by 2030. The key drivers of the market include the improving healthcare infrastructure, growing consumer awareness, and rising disposable incomes. The prominent players of the India Breast Pump Market are Advin Healthcare, Chemco, NaugraMedical, Medicon Healthcare, Akshar Pharma, and Amkay, among others.

PUBLISHED: Sep, 2024 | FORMAT: PPT | LAST UPDATED: Sep, 2024 | PRICE: $3999

Pharmaceuticals

Brazil Cancer Induced Bone Disease Therapeutics Market

Brazil Cancer Induced Bone Disease Therapeutics Market valued at $33 Mn in 2022, projected to reach $55 Mn by 2030 with a 6.8% CAGR. The key drivers of this industry include the rising incidence of cancer, improved diagnostics and treatment, and the potential for local manufacturing. The industry is primarily dominated by players such as Advaxis, CancerVax, Pfizer, Takeda, Gradalis, Hikma, and Zentalis among others.

PUBLISHED: Apr, 2024 | FORMAT: PPT | LAST UPDATED: Apr, 2024 | PRICE: $3999

Pharmaceuticals

Canada Congestive Heart Failure Therapeutics Market Analysis

The Canada Congestive Heart Failure Therapeutics Market is anticipated to experience a growth from $0.824 Bn in 2022 to $1.294 Bn by 2030, with a CAGR of 5.8% during the forecast period of 2022-2030. The key drivers of the Canadian congestive Heart Failure Therapeutics Market include the increasing prevalence of risk factors leading to CVS disorders, advancements in medical technology and intervention options, and supportive government schemes and reimbursement strategies. The Canada Congestive Heart Failure Therapeutics Market encompasses various key players across different therapeutic segments, including AbbVie, Amgen, AstraZeneca, Bayer, Bristol Myers Squibb, Johnson & Johnson, Apotex, Paladin Labs, Pharmascience, Sandoz, etc, among various others.

PUBLISHED: Jun, 2024 | FORMAT: PPT | LAST UPDATED: Jun, 2024 | PRICE: $3999

Digital Health

UK Digital Biomarkers Market Analysis

UK Digital Biomarkers Market was valued at $75.40 Mn in 2023 and is predicted to grow at a CAGR of 20.3% from 2023 to 2030, to $274.94 Mn by 2030. The key drivers of this industry include the high prevalence of chronic diseases, focus on preventative healthcare, government initiatives, and growing interest in personalized medicine. The industry is primarily dominated by ActiGraph LLC, AliveCor Inc., Koneksa, and Altoida Inc. among others.

PUBLISHED: Jul, 2024 | FORMAT: PPT | LAST UPDATED: Jul, 2024 | PRICE: $3999

Healthcare Services

Canada Medication Access Programs Market Analysis

The Canada Medication Access Programs Market was valued at $439.2 Mn in 2023 and is predicted to grow at a CAGR of 14.6% from 2023 to 2030, to $1140 Mn by 2030. The key drivers of this industry include chronic disease prevalence, rising healthcare costs, and pharmaceutical support. The industry is primarily dominated by players such as Gilead Sciences, Takeda Pharmaceuticals, Pfizer, and Novartis among others.

PUBLISHED: Sep, 2024 | FORMAT: PPT | LAST UPDATED: Sep, 2024 | PRICE: $3999

subscribe to our newsletter
up